Dominic Smethurst
Technik-/Wissenschafts-/F&E-Leiter bei CORBUS PHARMACEUTICALS HOLDINGS, INC.
Vermögen: 2 Mio $ am 30.04.2024
Profil
Dominic Smethurst is a Member at The Royal College of Physicians and a Member at the Faculty of Pharmaceutical Medicine.
He is also the Chief Medical Officer at Corbus Pharmaceuticals Holdings, Inc. since 2024.
Previously, he held positions such as Vice President-Oncology & Global Therapeutic Area at ICON plc, Chief Medical Officer at Bicycle Therapeutics Plc from 2020 to 2023, Chief Medical Officer at BerGenBio ASA, Chief Medical Officer at Nordic Nanovector ASA in 2020, and Chief Medical Officer at Tusk Therapeutics Ltd.
from 2016 to 2018.
Dr. Smethurst completed his undergraduate degree at the University of Cambridge and his graduate degree at Christ's College (United Kingdom).
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
27.02.2024 | 50 000 ( 0,48% ) | 2 Mio $ | 30.04.2024 | |
03.01.2023 | 23 574 ( 0,08% ) | 530 886 $ | 30.04.2024 |
Aktive Positionen von Dominic Smethurst
Unternehmen | Position | Beginn |
---|---|---|
CORBUS PHARMACEUTICALS HOLDINGS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 28.02.2024 |
Faculty of Pharmaceutical Medicine | Corporate Officer/Principal | - |
The Royal College of Physicians | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Dominic Smethurst
Unternehmen | Position | Ende |
---|---|---|
BICYCLE THERAPEUTICS PLC | Technik-/Wissenschafts-/F&E-Leiter | 31.03.2023 |
THOR MEDICAL | Technik-/Wissenschafts-/F&E-Leiter | 10.08.2020 |
Tusk Therapeutics Ltd.
Tusk Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Tusk Therapeutics Ltd. operates as a immuno-oncology company, focused on discovering and developing therapeutic antibodies. It provides immune modulating cancer therapeutics. The company is headquartered in Stevenage, the United kingdom. | Technik-/Wissenschafts-/F&E-Leiter | 01.09.2018 |
SV Health Investors LLP
SV Health Investors LLP Investment ManagersFinance SV Health Investors LLP (SV Health Investors) is a venture capital firm founded in 1994 by Peter McPartland. The firm is headquartered in London. | Private Equity Investor | - |
ICON PUBLIC LIMITED COMPANY | Corporate Officer/Principal | - |
Ausbildung von Dominic Smethurst
Christ's College (United Kingdom) | Graduate Degree |
University of Cambridge | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 4 |
---|---|
BERGENBIO ASA | Health Technology |
BICYCLE THERAPEUTICS PLC | Health Technology |
ICON PUBLIC LIMITED COMPANY | Commercial Services |
CORBUS PHARMACEUTICALS HOLDINGS, INC. | Health Technology |
Private Unternehmen | 4 |
---|---|
Nordic Nanovector ASA
Nordic Nanovector ASA Pharmaceuticals: MajorHealth Technology Nordic Nanovector ASA is a biopharmaceutical company, which engages in the development, marketing, and sale of medical products and equipment for anticancer therapeutics for haematological cancers. The firm offers the Betalutin which is an antibody radionuclide conjugates for the treatment of non-Hodgkin lymphoma. It operates through the following geographical segments: Norway, Switzerland, and the United Kingdom. The company was founded by Roy Hartvig Larsen, Oyvind Sverre Bruland, and Jostein Dahle on July 2, 2009 and is headquartered in Oslo, Norway. | Health Technology |
Faculty of Pharmaceutical Medicine | |
Tusk Therapeutics Ltd.
Tusk Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Tusk Therapeutics Ltd. operates as a immuno-oncology company, focused on discovering and developing therapeutic antibodies. It provides immune modulating cancer therapeutics. The company is headquartered in Stevenage, the United kingdom. | Health Technology |
SV Health Investors LLP
SV Health Investors LLP Investment ManagersFinance SV Health Investors LLP (SV Health Investors) is a venture capital firm founded in 1994 by Peter McPartland. The firm is headquartered in London. | Finance |